Related Experiment Videos
Carbamazepine lowers aggression: a review
1Whiting Forensic Institute, Middletown, Connecticut 06457.
The Bulletin of the American Academy of Psychiatry and the Law
|January 1, 1994
Summary
Carbamazepine shows promise in reducing aggressive behavior, with effects appearing rapidly. Further research is needed to fully establish its efficacy and understand its mechanisms for aggression management.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Growing reports suggest carbamazepine has an anti-aggressive effect.
- Despite limited rigorous studies, it's becoming a clinical practice for aggression reduction.
- The medication is used across a broad diagnostic spectrum.
Purpose of the Study:
- To summarize and evaluate existing investigations on carbamazepine's efficacy for reducing aggression.
- To promote wider clinical practice and further scientific study.
- To outline conceptual issues in aggression research and clinical considerations.
Main Methods:
- Review and evaluation of reported investigations and single case studies.
- Analysis of literature on carbamazepine's anti-aggressive effects.
- Exploration of the relationship between epilepsy and aggression.
Main Results:
- Carbamazepine demonstrates an anti-aggressive effect, often within days.
- The effect is observed across a broad range of diagnoses.
- Evidence, though based on limited patient numbers and rigor, supports its clinical use.
Conclusions:
- Carbamazepine is a viable option for reducing aggressive behavior.
- Further research is warranted to solidify its role and understand mechanisms.
- Clinical practice is evolving, necessitating a review of current evidence and considerations.